Skip to main content

Table 2 Treatment adherence outcomes in all patients with acromegaly receiving octreotide or lanreotide

From: Treatment adherence and persistence with long-acting somatostatin analog therapy for the treatment of acromegaly: a retrospective analysis

Treatment

N

Variable

N

Mean

SE

Minimum

Maximum

Octreotide

1127

Treatment time (days)

1127

418.5

14.9

0

1819

 

Number of injections

1127

10.8

0.4

1

68

 

MPR (%)

891

87

4

0.06

30

Lanreotide

181

Treatment time (days)

181

383.8

28.1

0

1454

 

Number of injections

181

11.1

0.8

1

49

 

MPR (%)

155

85

3

0.12

3.8

  1. Only one injection was logged and used for treatment time calculation
  2. N sample size, SE standard error, MPR medication possession ratio